Clinical Trials Directory

Trials / Completed

CompletedNCT00963560

Presbyopia-Correcting Intraocular Lenses (IOLs)

A Randomized, Subject-masked Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting IOLs

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
132 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with Presbyopia-Correcting Intraocular Lenses (IOLs).

Conditions

Interventions

TypeNameDescription
DEVICEReSTOR +3Bilateral implantation of the AcrySof ReSTOR Aspheric +3 Model SN6AD1 Intraocular lens (IOL) for the treatment of cataract.
DEVICECrystalens HDBilateral implantation of the Crystalens HD intraocular lens (IOL) for the treatment of cataract.
DEVICECrystalens AOBilateral implantation of the Crystalens AO intraocular lens (IOL) for the treatment of cataract.

Timeline

Start date
2009-08-01
Primary completion
2011-03-01
First posted
2009-08-21
Last updated
2011-08-09
Results posted
2011-08-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00963560. Inclusion in this directory is not an endorsement.

Presbyopia-Correcting Intraocular Lenses (IOLs) (NCT00963560) · Clinical Trials Directory